Concepedia

Nader Pourhassan

NP

Statistics

Publications

10

Citations

433

H-Index

10

Active since

2018

Affiliations

Oregon Health & Science University(Current)

Cornell University

Oregon National Primate Research Center

Quest Clinical Research (United States)

Weill Cornell Medicine

Nader Pourhassan is an author at Oregon Health & Science University specializing in immunology, infectious diseases, and antiviral therapy.

ORCID

Publications per year

2018–2022

10

Publications

10

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · International Journal of Infectious Diseases · 2020 · 147 citations · Full text

, , +17

Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19

Bruce K. Patterson, Harish Seethamraju, Kush Dhody et al. · medRxiv · 2020 · 104 citations · Full text

, , +17

PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection

Kush Dhody, Nader Pourhassan, Kazem Kazempour et al. · HIV Clinical Trials · 2018 · 50 citations

, , +16

Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome

Norman Gaylis, Angela Ritter, Scott A. Kelly et al. · Clinical Infectious Diseases · 2022 · 28 citations · Full text

, , +16

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab

Xiao Chang, Helen L. Wu, Gabriela M. Webb et al. · Frontiers in Immunology · 2021 · 26 citations · Full text

, , +14

1–5 of 10